我要投票 雷氏在珍珠粉行业中的票数:894
· 外 推 电 报 ·
2025-12-27 20:02:51 星期六

【雷氏是哪个国家的品牌?】

雷氏是什么牌子?「雷氏」是 上海雷允上药业有限公司 旗下著名品牌。该品牌发源于上海,由创始人苏俊英在1998-11-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷氏品牌出海!将品牌入驻外推网,定制雷氏品牌推广信息,可以显著提高雷氏产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

百年老字号雷允上药店始建于苏州,发迹于上海,迄今已有近三百年历史。公元1734年(清雍正十二年)创始于苏州;1860年(清咸丰十年)设“申号”于上海新北门外,1934年设“北号”于河南北路天后宫桥(今河南路桥)北堍,1937年又设北号支店于静安寺路(今南京西路)。由于药店规模较大,资产雄厚,影响面广,早年就被国药同业公认为上海中药店“四大户"之一。中国改革开放以来,经资产重组,工商联手,今日上海雷允上药业雄风再现,成为中国中药行业的强者。雷允上药业历史渊源>>

上海雷允上药业有限公司是上药集团上海市药材有限公司为投资主体成立的集农工商、科工贸、产学研于一体的大型中药企业,历年被认定为上海市高新技术企业、上海市文明单位,是上海市第一批知识产权示范企业,旗下“雷氏”品牌被认定为中国驰名商标,并以20.8亿的品牌价值荣获中国500最具价值品牌称号。近年来,公司及其品牌先后获得中国百年中药老字号企业、最具价值的上海老商标、上海市出口名牌、上海市装备制造业与高新技术产业自主创新品牌、上海现代服务业百强等荣誉称号。

公司拥有严格的质量保证体系。从中药产业链源头GAP规范标准入手,严格原药材采购控制。拥有国家GMP规范要求的中药产业化制造基地,能生产20多个剂型500多个品种。拥有包括中药材、中成药、保健品和名贵参茸等在内的强大的专业营销网络,辐射全国,足迹遍及东南亚、北美、欧洲等地。雷允上连锁多年被评为最具影响力特许品牌。六神丸、雷氏珍菊降压片、雷氏炮天红酒等产品历年被评为上海市名牌产品,在海内外均享有较高的声誉。多年坚持开展社区健康服务,2006年赢得了“全国卫生进社区——相约健康社区行”社会公益奖。

公司传承“至诚至信,关爱生命”的企业追求,竭尽所能地致力于服务社会、造福人类的伟大事业,为弘扬祖国优秀中医药文化,为人类的健康贡献力量。

英文翻译:The century old drugstore under leiyunshang pharmaceutical was founded in Suzhou and started in Shanghai. It has a history of nearly 300 years. It was founded in Suzhou in 1734 (the 12th year of Yongzheng reign in the Qing Dynasty); in 1860 (the 10th year of Xianfeng reign in the Qing Dynasty), it was set up outside the new North Gate of Shanghai; in 1934, it was set up in the north end of hougongqiao (now Henan Road bridge), North Henan Road; in 1937, it was set up in Jingansi Road (now Nanjing West Road). Due to the large scale, strong assets and wide influence of drugstores, they have been recognized as one of the "four big families" of Shanghai Traditional Chinese medicine stores by the pharmaceutical industry in the early years. Since China's reform and opening up, through asset restructuring and joint efforts of industry and commerce, the pharmaceutical industry of Shanghai leiyunshang Pharmaceutical Co., Ltd. has reappeared today, becoming a strong player in the Chinese traditional medicine industry. The history of pharmaceutical industry under leiyunshang pharmaceutical & gt; & gt; Shanghai leiyunshang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise established by Shanghai Pharmaceutical Group Co., Ltd. as the main investor, integrating agriculture, industry and commerce, science, industry and trade, production, learning and research. It has been recognized as a high-tech enterprise in Shanghai and a civilized unit in Shanghai. It is the first batch of intellectual property demonstration enterprises in Shanghai. Its "Leishi" brand is recognized as a well-known trademark in China Won the title of China's 500 most valuable brand with a brand value of 2.08 billion. In recent years, the company and its brand have successively won the honorary titles of China's century old brand enterprise of traditional Chinese medicine, the most valuable old trademark of Shanghai, Shanghai Export famous brand, independent innovation brand of Shanghai equipment manufacturing industry and high-tech industry, and top 100 modern service industry of Shanghai. The company has a strict quality assurance system. Starting from the gap standard of the source of traditional Chinese medicine industry chain, strictly control the purchase of original Chinese medicine. It has the industrialization manufacturing base of traditional Chinese medicine required by the national GMP standard, and can produce more than 20 dosage forms and more than 500 varieties. It has a strong professional marketing network including traditional Chinese medicine, Chinese patent medicine, health care products and rare ginseng antler, covering the whole country, covering Southeast Asia, North America, Europe and other places. Leiyunshang chain has been rated as the most influential franchise brand for many years. Liushenwan, Zhenju hypotensive tablet and Baotian red wine have been rated as famous brand products in Shanghai over the years, enjoying a high reputation at home and abroad. In 2006, it won the social public welfare award of "national health into the community - meeting healthy communities". The company inherits the enterprise pursuit of "sincere and trustworthy, caring for life", devotes itself to the great cause of serving the society and benefiting the human as much as possible, promotes the excellent traditional Chinese medicine culture of the motherland and contributes to the health of human beings.

本文链接: https://www.waitui.com/brand/942bfee42.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中银理财黄党贵:建议适当放松跨境投资额度限制 增加理财公司专属QDII额度

12月27日,中银理财董事长黄党贵今日在“中国财富管理50人论坛2025年会”上表示,理财公司要积极有序推动跨境理财的发展。“十五五”期间人民币在国际支付领域广泛应用,必然带来全球人民币投资显著增长,两者相互促进、相互依赖。为促进人民币国际化顺利推进,建议进一步扩展离岸市场的深度和广度,通过丰富离岸人民币资管产品可以提供“两头在外”的资金配置便利。同时,建议适当放松跨境投资额度限制,例如增加理财公司专属QDII额度等。(财联社)

3分钟前

英国养老基金据悉正就收购Center Parcs的15%到20%股份进行洽谈

英国养老基金据悉正就收购Center Parcs的15%到20%股份进行洽谈,对Center Parcs的估值约为45亿英镑。(财联社)

3分钟前

网易集团执行副总裁丁迎峰宣布退休,后续担任公司顾问

36氪获悉,北京时间12月27日凌晨(美股交易日期间),网易集团发布公告,宣布网易集团执行副总裁、互动娱乐事业部负责人丁迎峰(丁丁)将于2025年12月31日正式退休。后续他将继续担任公司顾问一职。公告中,网易CEO丁磊表示:“我们衷心感谢丁迎峰先生的奉献和贡献。他为公司旗舰游戏的成功做出了卓越贡献,并在公司研发和运营能力的建设中发挥了关键作用。”

3分钟前

同心医疗科创板IPO获受理

据上交所官网披露,苏州同心医疗科技股份有限公司(以下简称“同心医疗”)科创板IPO申请获受理。招股书显示,同心医疗成立于2008年,长期专注于全磁悬浮式心室辅助装置(以下称人工心脏)的研究、开发与商业化,基于完整自主可控的技术和在中国、美国、欧洲的经营实体,构建了辐盖全球主流市场的业务体系,目前已在中国、美国产生了快速增长的收入。截至招股书签署日,CH-VAD已在80余家医院完成670余例植入,销售收入从2022年的827.20万元迅速增长至2024年的6705.98万元。(中国证券报)

3分钟前

新修订的渔业法将于明年5月1日施行

据央视新闻,十四届全国人大常委会第十九次会议27日表决通过新修订的渔业法,将于2026年5月1日起施行。这部新修订的法律,将进一步促进渔业提质增效、绿色发展。对渔业养殖业,新修订的渔业法明确,国家鼓励单位和个人科学合理利用适于养殖的水域、滩涂发展养殖业,支持资源节约、环境友好、质量安全的养殖模式。对渔业捕捞业,明确国家根据捕捞量低于渔业资源增长量的原则,确定渔业资源的总可捕捞量,实行捕捞限额制度。对渔业资源保护,明确国家加强重要渔业水域保护。国家加强对水产种质资源的调查、收集、整理、鉴定、登记、保存,建立水产种质资源库。禁止违反禁渔区、禁渔期的规定从事捕捞活动,禁止违规垂钓。(央视新闻)

3分钟前

本页详细列出关于雷氏的品牌信息,含品牌所属公司介绍,雷氏所处行业的品牌地位及优势。
咨询